Standout Papers

PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy 2021 2026 2022 2024255
  1. PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy (2021)
    Jinhua Liu, Zichao Chen et al. Frontiers in Pharmacology

Immediate Impact

1 from Science/Nature 43 standout
Sub-graph 1 of 19

Citing Papers

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
2024 Standout
Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies
2024 Standout
3 intermediate papers

Works of Jibiao Wu being referenced

PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
2021 Standout

Author Peers

Author Last Decade Papers Cites
Jibiao Wu 295 143 165 219 25 679
Qing Yang 284 118 155 117 31 678
Fabiola A. Sánchez 323 103 172 124 26 814
Haiyan He 372 197 137 114 34 652
Shunqin Long 283 147 146 301 22 773
Xiaoqun Ye 381 199 73 178 40 816
Xiongwei Huo 310 155 71 229 18 690
Lijuan Huang 216 84 184 164 26 605
Yuan Chen 434 159 85 137 39 791
Liang Wang 290 130 126 196 41 684
Suchismita Mohanty 386 117 217 204 24 778

All Works

Loading papers...

Rankless by CCL
2026